REDWOOD CITY, CA--(Marketwire - July 30, 2009) - Facet Biotech Corporation (NASDAQ: FACT) today announced that the company will participate at the upcoming BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York on Wednesday, August 5, 2009 at 8:30 a.m., Eastern Time.
A live webcast of the presentation and the Q&A session will be available through the Facet website at www.facetbiotech.com. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. A replay will be available at www.facetbiotech.com starting approximately one hour after completion of the webcast.
About Facet Biotech
Facet Biotech is a biotechnology company dedicated to advancing its pipeline of four clinical-stage products, leveraging its research and development capabilities to identify and develop new oncology drugs and applying its proprietary next-generation protein engineering technologies to potentially improve the clinical performance of protein therapeutics. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.
NOTE: Facet Biotech and the Facet Biotech logo are considered trademarks of Facet Biotech Corporation.
Contact:
Jean Suzuki
Investor Relations
(650) 454-2648
jean.suzuki@facetbiotech.com
